- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Ventrus Biosciences Inc+ Add to Watchlist
VTUS:US1.4400 USD 0.0200 1.37%
As of 20:10:00 ET on 03/11/2014.
Company Profile for Ventrus Biosciences Inc (VTUS)
Ventrus Biosciences Inc. is a development stage pharmaceutical company. The Company is focused on late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. Ventrus's lead products are topical treatments for hemorroids, which targets a specific serotonin receptor.
Ventrus Biosciences Inc
Key Executives for Ventrus Biosciences Inc (VTUS)
|Russell H EllisonChairman/President/CEO||David J BarrettChief Financial Officer|